Adaptation and Feasibility of the Community-Based Anxiety Program

Recruiting

7-17 years

All

Phase N/A

60 participants needed

1 Location

Brief description of study

Anxiety is very common in autistic youth. Recently, an intervention has been created by the investigators to target these symptoms in autistic youth in a community setting. The purpose of this study is to determine the feasibility of implementing this treatment in community care centers.

Detailed description of study

As many as 50% of autistic youth have at least 1 anxiety disorder. Cognitive-behavioral therapy (CBT) for autistic youth is effective at treating anxiety, but access is limited. The researchers have tailored this treatment to make it more accessible to families in the participants' home communities. The purpose of this project is to investigate how feasible it is to implement Community-Based Anxiety Programs Tailored for Autism (CAPTA) in community settings.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Psychological Research
Age: Between 7 Years - 17 Years
Gender: All

Inclusion Criteria

The child is between the ages of 7 to 17 upon enrollment with an established autism spectrum disorder diagnosis (ASD).
The child has clinically elevated symptoms of anxiety.
Anxiety is the primary concern, and the child is appropriate for intervention focus.
Child has a verbal IQ ≥ 70.
One parent/guardian is able and willing to participate (i.e., available during therapy sessions, attend study assessments).
Child is eligible to receive services at the participating clinic.
Both parent and child can read and/or understand English and/or Spanish.
Both parent and child reside in Texas or Pennsylvania.

Exclusion Criteria

The child has a diagnosis of psychotic disorder.
The child has severe current suicidal/homicidal ideation and/or self-injury requiring medical intervention.
The child is receiving concurrent psychotherapy for anxiety.
If child is taking psychotropic medication, regimen must have been started 8 weeks ago and stable for the past 4 weeks (or started 4 weeks ago and stable for the past 2 weeks for stimulants, benzodiazepines, and antipsychotics).

Updated on 01 Aug 2024. Study ID: 855393

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).